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A 24-hour light and dark cycle-dependent rhythmicity pervades physiological processes in
virtually all living organisms including humans. These regular oscillations are caused by
external cues to endogenous, independent biological time-keeping systems (clocks). The
rhythm is reflected by gene expression that varies in a circadian and specific fashion in dif-
ferent organs and tissues and is regulated largely by dynamic epigenetic and post-transcrip-
tional mechanisms. This leads to well-documented oscillations of specific electrolytes,
hormones, metabolites, and plasma proteins in blood samples. An emerging, important
class of gene regulators is short single-stranded RNA (micro-RNA, miRNA) that interferes
post-transcriptionally with gene expression and thus may play a role in the circadian varia-
tion of gene expression. MiRNAs are promising biomarkers by virtue of their disease-spe-
cific tissue expression and because of their presence as stable entities in the circulation.
However, no studies have addressed the putative circadian rhythmicity of circulating, cell-
free miRNAs. This question is important both for using miRNAs as biological markers and
for clues to miRNA function in the regulation of circadian gene expression. Here, we investi-
gate 92 miRNAs in plasma samples from 24 young male, healthy volunteers repeatedly
sampled 9 times during a 24-hour stay in a regulated environment. We demonstrate that a
third (26/79) of the measurable plasma miRNAs (using RT-qPCR on a microfluidic system)
exhibit a rhythmic behavior and are distributed in two main phase patterns. Some of these
miRNAs weakly target known clock genes and many have strong targets in intracellular
MAPK signaling pathways. These novel findings highlight the importance of considering
bio-oscillations in miRNA biomarker studies and suggest the further study of a set of specific
circulating miRNAs in the regulation and functioning of biological clocks.
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Introduction
The levels of many biological molecules vary according to a biological rhythm, i.e., a cyclic
change that roughly follows a 24-hour period. The periodicity is endogenously generated (cir-
cadian rhythms) but typically instructed (probably through dynamic epigenetic changes [1])
by the day/night light cycle (the diurnal-nocturnal cycle). Apart from being of considerable
basic interest in physiology and disease, awareness of such biomolecular oscillations is of
obvious importance for measurements in laboratory medicine and for studies developing e.g.
diagnostic biomarkers. In humans, the principal circadian oscillator is found in the suprachi-
asmatic nucleus (SCN) of the hypothalamus. Several peripheral local clocks supplement it and
together they coordinate the physiological cycles [2;3]. Most circadian gene expression is
organ specific and in the mouse genome up to half of all genes oscillate according to a circa-
dian rhythm somewhere in the organism [4]. In the pineal gland which is controlled by the
SCN almost 60% of 4,459 genes exhibit significant day/night expression changes [5]. Proper
functioning of the clock system requires an intricate interplay between transcriptional, post-
transcriptional, and post-translational mechanisms [6]. Recently, several studies have shown
that circadian oscillations of protein expression (involving phases, periods, and amplitudes) to
a much larger extent than previously envisioned are controlled post-transcriptionally [7;8]. As
an example, in the murine hepatic proteome about 20–50% of the transcripts representing
5–10% of total protein were not cyclic despite cyclic protein levels [9–11]. Also, next-genera-
tion sequencing studies indicate that 80% of clock-controlled genes are not rhythmically tran-
scribed [12]. Post-transcriptional circadian regulation could, among other factors, be due to
micro-RNA (miRNA) [13–16], and in one example involving miRNAs interacting with clock
genes Bmal1 and Clock in mice, miR-219 and miR-132 were demonstrated to be clock gene
and light-regulated, respectively [17]. Also, circulating miRNAs in mice interacting with
Bmal1 were shown to be rhythmically fluctuating suggesting that they act as extracellular sig-
nals regulating peripheral circadian oscillators [18]. In addition, other noncoding RNAs are
rhythmic in specific tissues [19], and because a single miRNA has many potential mRNA tar-
gets, one fluctuating miRNAmay orchestrate fluctuations of many different proteins simulta-
neously. However, while several miRNAs and indeed the pre-miRNA processing machinery
(Dicer RNase) are rhythmic in specific tissues such as the SCN, the eyes, and liver [8;20] and
may have circadian functions [21], it is not known if any of the circulating miRNA in human
blood exhibits diurnal variation. It is also not known if any oscillating circulating, cell-free
miRNA would function as a regulator of peripheral circadian oscillators and/or simply is a
reflection of changing miRNA levels at the sites of central and peripheral oscillators. Yet
another possibility is that some miRNA oscillations may occur because the miRNAs are tran-
scribed together with oscillating protein-coding RNA. In any event, no studies of the physio-
logical rhythmicity of extracellular miRNAs in the human circulation have been presented.
This is important also because the circulating pool of miRNA is under scrutiny as a convenient
reservoir of information on disease and functions in numerous conditions and diseases. Here,
we study a panel of 92 miRNAs in plasma from healthy individuals. The miRNA panel
includes miRNAs that are expressed in the pineal gland or have been reported as rhythmically
expressed or as implicated in regulating oscillatory regulation of pineal gland/retinal gene
expression in animal studies [6;8;17;22–27] or have been predicted from literature and bioin-
formatics screening and shown in experiments with cellular miRNA to fluctuate [28;29]. Also,
we include miRNAs that are known to be detectable in plasma or are abundant in the central
nervous system [30;31]. This panel of miRNAs is here quantitatively determined in plasma
samples obtained from a group of 24 healthy young men at regular 3-hr intervals in a con-
trolled environment during 24 hours. Of the 79 miRNA that could be reliably measured we
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find n = 26 that are significantly rhythmic and which represent two main phase patterns. This
is the first report of diurnal variations of circulating, extracellular human miRNAs. The find-
ings add another important intra-individual variable to consider in the design and interpreta-
tion of biomarker development studies and suggest that investigations of functional roles of
these miRNAs in the regulation of biological clocks are warranted.
Materials and Methods
Study design
In the present study, samples from the Bispebjerg study of diurnal variations [32] were used to
analyze variations of circulating cell-free micro RNA. In brief, 24 healthy Caucasian male vol-
unteers (mean age 26 years) stayed for 24 hours at the hospital ward with 15 hours of wakeful-
ness in ordinary day/room light (mean light intensity 219 lux) and 9 hours of sleep from 23:00
h to 08:00 h in the dark. Every third hour (nine time points in total), each participant had
blood samples taken; sampling during the night was guided by red light (19 lux). During the
awake period, the participants were allowed to carry out low intensity activities and standard-
ized normal calorie meals were served at 09:30 h, 13:00 h and 19:00 h. The volunteers’ regular
routine of diurnal activity and nocturnal sleep were validated by the presence of a normal
24-hour melatonin pattern [32]. All participants signed an informed written consent before
inclusion and the study was conducted according to the Helsinki declaration of 1975, as revised
in 1983. The Regional Scientific Ethical Committee of the Capital Region of Denmark (protocol
number H-B-2008-011) and the Danish Data Protection Agency (journal number 2008-41-
1821) approved the study.
Analysis of circulating microRNA
A total of 216 plasma samples representing the 9 time points from the 24 study subjects were
included. Blood samples for analysis of miRNA were drawn in K3EDTA (ethylene diamine tet-
raacetic acid) plasma tubes (Greiner Bio-one, Frickenhausen, Germany). Immediately after
sampling plasma was isolated by centrifugation at 1,500 g at 20°C for 10 minutes and stored
at −80°C until analysis.
RNA purification. A total RNA purification kit (Norgen Biotek Corp., Ontario, Canada)
was used to purify RNA from 100 μL plasma according to the instructions of the manufacturer
with small modifications: 10 mM dithiothreitol (DTT) (Sigma-Aldrich Co. LLC, Germany)
and 1.7 pM synthetic C. elegansmiR-54 and -238 (Tag Copenhagen A/S, Denmark) were
added into lysis buffer. One uL of RNAse inhibitor (20 U/μL) (Applied Biosystems (ABI), Fos-
ter city, CA, USA) was added to every elution tube before elution of RNA. Purified RNA sam-
ples were kept at -20°C until used.
Reverse transcription. Reverse transcription (RT) was performed by the TaqMan micro-
RNA Reverse Transcription Kit (Applied Biosystems (ABI), Foster city, CA, USA) according to
the instructions of the manufacturer with modifications: The RT-primer-mix consisted of
equal volumes of each of 48 different 5x RT miR-specific stem-loop primers (Applied Biosys-
tems (ABI), Foster city, CA, USA). Each reverse transcription reaction volume was 10 μL using
1 μL Multiscribe reverse transcriptase, 3 μl RT-primer-mix, 1 μL 10 X buffer, 0.2 μL 100 mM
dNTPs, 0.15 μL RNase inhibitor and 4.65 μL RNA purified from plasma. Reverse transcription
was performed on an ABI 2720 Thermal Cycler (Applied Biosystems, Foster City, CA, USA)
using a standard protocol (16°C, 30 min; 42°C, 30 min; 85°C 5 min; hold at 4°C). Reverse tran-
scribed samples (cDNA) were kept at -20°C until used. The same procedure was used for a sec-
ond set of miRNAs (S1 Table).
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Preamplification. For each of the 2 sets of analyses that were performed (cf. S1 Table) spe-
cific target amplification of the cDNA was accomplished using the TaqMan PreAmp master
mix (Applied Biosystems (ABI), Foster city, CA, USA) with a mix of the TaqMan MicroRNA
Assays (ABI) consisting of equal volumes of the 48 different 20x assays diluted with 1x TE
buffer to a final concentration of 0.2x. Preamplification mixtures (10 μL) contained cDNA
(diluted 1:3 with H2O) 2.5 μL, mixed with 5 μL 2x TaqMan PreAmp master mix and 2.5 μL of
the 0.2x TaqMan miR-assay mix. Preamplification was performed on an ABI 2720 Thermal
Cycler (Applied Biosystems, Foster City, CA, USA) with the following program steps: 95°C for
10 min, 16 cycles of 95°C, 15 s and 60°C, 4 min, then hold at 4°C. Preamplified samples were
kept at -20°C until used.
Quantitative PCR. Preamplified samples (diluted 1:5 with H2O) and TaqMan 20x assays
miRNAs were applied to primed 96.96 dynamic array chips using loading and assay reagents
according to the manufacturer (Fluidigm Corp., USA). All miR-assays were performed in
duplicate. The samples of this study were analyzed on three 96x96 chips (Fluidigm Corp.,
USA) with two different 48-miRNA assay panels (for a total of 6 chips). After loading the reac-
tion chambers using the integrated fluid circuit (IFC) HX controller from Fluidigm, the real-
time PCR including image capture after each cycle was performed in a BioMark real-time PCR
system (Fluidigm Corp., USA) using single probe (FAM-MGB, reference: ROX) settings and
GE 96x96 standard v1 protocol with 40 cycles. Data processing took place using the Fluidigm
real-time PCR analysis software (v. 4.1.2).
Data handling. The “auto detectors” setting was chosen for data from all of the chip runs.
Data with average Cq values above 35 were excluded from data sets. Each remaining average
Cq value was technically normalized with the average Cq of the spike-in synthetic miRNAs
(cel-miR-54 and cel-miR-238) for that particular sample yielding the -ΔCq values (= average
Cq of cel-miR-54 and cel-miR-238 − average Cq of the hsa-miR). This technical normalization
is included to level out variations during the purification steps. These -ΔCq values were further
normalized with the row-specific average ΔCq value of miRNAs that were detected in all sam-
ples to correct for variations in total input RNA. Thus, we used the average -ΔCq of 40 miRNAs
in the first 48-miRNA panel and of 20 miRNAs in the second 48-miRNA panel (S1 Table) for
each row to subtract from all miRNA-ΔCq values in each sample (row). These technically and
row mean-normalized expression values were then used for the rhythmicity analysis. The nor-
malized miRNA data are shown in S2 Table. Additionally, for the first miRNA panel (where
miR-16 was included), we also normalized the data with row-specific miR-16 values instead of
using row mean-normalization (data included in S3 Table).
Rhythmicity analysis
As described earlier [32], under the assumption of 24-hour periods, the time-related miRNA
expression data for the complete set of 216 results for each miRNA were fitted into a combined
cosine and sine function and analyzed for possible diurnal rhythms. The methods for cosinor-
rhythmometry for groups including the p-value calculation after linearization correspond to
previously published methods [33]. The 24-hour rhythms were characterized by the rhythm
parameters: mesor (rhythm-adjusted average about which oscillation occurs), amplitude (the
difference between the peak (zenith) and lowest (nadir) value of the fitted cosinor curve) and
time of peak and nadir [33]. Whether a parameter exhibited a clear diurnal rhythm was evalu-
ated from the p-value and the shape of the cosine curve. The time-dependent distribution of
the individual observations of the miRNAs presenting diurnal rhythms was graphically sum-
marized as the best fitting cosine curve against time. At each time point, mean values and stan-
dard errors of the mean are shown. The data analyses were performed using SAS version 9.3
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(SAS Institute Inc, Cary, NC, USA). A p-value< 0.05 was considered significant. All data,
including graphs of all detected miRNAs (S1 Fig) and the rhythmicity analysis data (S1 and S2
Files) are included as Supporting Information.
MiRNA target analysis
Analysis of individual miRNA targets was based on miRTarBase 6.0 (http://mirtarbase.mbc.
nctu.edu.tw/). The miRNAs were also investigated for targets in known central clock genes
(CRY1/2, PER1/2/3) and in the MAPK pathway. For MAPK, all the genes in this pathway were
identified through the KEGG homepage (in total 225 genes) and compared to all stringently
validated genes (607 unique genes) regulated by the miRNAs found in the study (validated by 2
or more of the following methods: reporter assay, Western blot, or qPCR). Pathway representa-
tion of miRNA targets was accomplished using the KEGG pathway database (http://www.
genome.jp/kegg-bin/show_pathway?org_name=hsa&mapno=04010&mapscale=&show_
description=hide), target genes were marked in red, using the “User data mapping” function.
The miRNA targets were mapped to KEGG and Reactome pathways using the program
gProfileR (v. 0.5.3) through R (v. 3.1.3). Organism was set to “hsapiens” and significant to
“TRUE”, otherwise default settings were used. The p-values obtained from gProfileR were used
as values for heatmaps and all miRNA-pathway combinations that were not significant were
assigned the value 0.05 for visualization. Heatmaps were made using the gplots package (vs.
2.17.0), trace was disabled, otherwise default settings were used.
Results and Discussion
Diurnal fluctuations of plasma miRNAs in healthy volunteers
A normal 24-hour rhythm of the participants was confirmed by analyzing for melatonin that
exhibited a clear rhythm (p< 0.0001) with an amplitude (amp) of 19.84 pg/ml and a nightly
peak level at 03:34 h in the study samples as previously reported [32].
We found 79 of the assayed 92 miRNAs to be reliably detected. Excluded miRNAs either
gave no or weak (Cq> 35) signal or only signals in a few (less than half) of the samples. To
date there are no universally accepted circulating miRNAs that can be used as normalizing
housekeeping genes and the concentration of the purified miRNA is too low to be determined
UV spectrophotometry. Data were therefore normalized in two steps. First, normalization for
technical variation was accomplished by using the values of spike-in synthetic non-mammalian
miRNA. Second, normalization for variations in input total miRNA was accomplished by row
mean-normalization [34] using the mean Cq value in each row (sample) of miRNAs expressed
in all samples. Specifically, the row mean of 40 miRNAs in the first panel-experiment and of 20
miRNAs in the second panel-experiment were used for normalization.
Of the 79 detected miRNAs 26 were significantly (p< 0.05) rhythmic (Figs 1 and 2; in S1
Fig is included all the graphs of the 79 detected miRNAs). The time-of-day dependent distribu-
tion of the individual observations of the miRNAs presenting diurnal rhythms is listed in
Table 1. In the graphs the sleep periods are indicated in grey and miRNAs peaking at night
(n = 12, Fig 1) and during day (n = 14, Fig 2) are shown in the respective figures.
As an alternative to row mean-normalization it might be possible to use single miRNAs as
endogenous controls in the same way as small nucleolar RNAs are used in tissue and cell-
miRNA profiling. In extensive method comparisons between serum and plasma, miR-16
emerged as one possible candidate for such an abundant, endogenous circulating miRNA nor-
malizer [35]. Other studies, however, have not found miR-16 to be appropriate for this pur-
pose. One reason is that it is associated with at least 10 non-neoplastic diseases [36] and is
differently reported as a stable and a disease-associated circulating miRNA even in studies of
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the same disease [37]. Also, no studies have addressed the rhythmicity of miR-16 itself in the
circulation. Here, we find it quite stable (S2 Fig) during the 24-hour period. The two normali-
zation methods (cf. side-by-side comparison in S3 Fig) yield overall quite similar time-curves,
but miR-16 normalization leads to less significant miRNAs found in the rhythmicity analysis,
probably due to the more pronounced variation of the ΔCq-values at each time point. Thus,
when miR-16 was used for normalization instead of row mean-normalization of the first
miRNA panel data, a total of 9 miRNAs, all part of the miRNAs emerging as significantly
rhythmic after row mean-normalization, were confirmed. However, 9 others were not found
(S1 Table) and in view of this and of the lack of consensus regarding single-miRNA normaliz-
ers we decided to use the row mean-normalization method throughout.
We compared our findings with mammalian miRNAs bioinformatically predicted to target
clock genes, their isoforms, and genes associated with a pattern of circadian protein expression
despite constitutively expressed mRNA [28]. In the present study we included 17 of the 38
miRNAs equally predicted by three different miRNA-target prediction programs and with vali-
dated rhythmic target genes. Of these 17 miRNAs, 5 (miRs-9, -29b, -96, -219, and -346) were
not reliably detected and 10 miRNAs did not exhibit diurnal oscillation while 2 (miRs-24 and
Fig 1. Nocturnal miRNAs. Sleep periods are indicated in grey. Individual points represent the mean and SEM of the values of the 24 test individuals.
doi:10.1371/journal.pone.0160577.g001
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-27a) did show a significant diurnal variation. Even though we do not find a significant diurnal
variation of miR-27b (p = 0.08) our data show that the closely related miR-27a (one nucleotide
difference) does exhibit rhythmicity (p = 0.02). In leukocytes miR-27b was previously shown to
display rhythmicity in samples from two out of five normal subjects [28]. In another study of
fluctuations of leukocyte miRNAs [29] miR-16 and miR-181a were shown to fluctuate in those
4 out of 6 subjects where the expression was highest at daytime. In our data, representing the
Fig 2. Diurnal miRNAs. Sleep periods are indicated in grey. Individual points represent the mean and SEM of the values of the 24 test individuals.
doi:10.1371/journal.pone.0160577.g002
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mean of 24 healthy volunteers, we do not find a concurrent rhythmic variation of these two
miRNAs. It is highly warranted in future studies to address the rhythmicity of the miRNA pre-
cursors (pri-miRs) in specific cell types, e.g. leukocytes to address if miRNA rhythmicity is
directly transcriptionally regulated.
The human homologues of mouse miRNAs -219a and -132 which exhibit rhythmic expres-
sion in mouse brain tissue and act as clock-transcription factor and light-regulated miRNAs,
respectively [17] were included in our study but miR-219a was found not to be detectable in
plasma, and miR-132 had a stable, non-cyclic expression. Also, while we were able to detect
miR-182 in plasma, it was not oscillating. Its pre-form has been reported to be modulating the
circadian clock and was abnormally processed in a study of depressive patients with sleep dis-
orders [24]. Regulation by other environmental factors such as e.g. food intake is possible, but
fasting was previously found not to affect the levels of 162 circulating human miRNAs [38].
This study identified miR-99a-5p and miR-139-5p as novel endogenous controls for serum
miRNA because of stable values across individuals. However, our data show that while the lev-
els of miR-99a-5p are not rhythmic they are quite variable (with a difference of 21% between
the highest and lowest mean values) during the 24-hour period. For miR-139-5p, the data in
fact show clear rhythmicity (p = 0.0006). None of these two miRNAs therefore appears to be
optimal as endogenous normalizers for plasma miRNAs.
Table 1. Rhythmic, circulatingmiRNAs (p < 0.05) ranked according to their peak time (Max time).
miRNA Mesor Amplitude Max time Min time P-value
hsa-miR-375 -6.4 1.2 00:32 12:32 <0.0001
hsa-miR-150-5p 0.4 0.5 01:54 13:54 0.001
hsa-miR-378a-3p 9.4 0.4 01:56 13:56 0.02
hsa-miR-206 -4.0 0.6 01:59 13:59 0.0009
hsa-miR-28-3p 1.5 0.7 02:17 14:17 0.02
hsa-miR-708-5p 3.0 0.7 02:20 14:20 0.02
hsa-miR-222-3p 2.0 0.6 02:38 14:38 0.02
hsa-miR-383-5p 0.4 0.3 03:42 13:42 0.02
hsa-miR-155-5p 9.2 0.5 04:25 16:25 <0.0001
hsa-miR-363-3p 2.7 0.6 04:33 16:33 0.006
hsa-miR-483-5p 4.8 0.3 04:33 16:33 0.0004
hsa-miR-208a-3p 8.0 0.6 06:29 18:29 0.003
hsa-miR-27a-3p -3.7 0.3 09:52 21:52 0.02
hsa-miR-223-3p 3.4 0.3 11:38 23:38 0.02
hsa-miR-24-3p -0.3 0.4 12:23 00:23 0.02
hsa-miR-19-3p -1.4 0.3 13:04 01:04 0.04
hsa-miR-140-5p -2.3 0.4 14:19 02:19 <0.0001
hsa-miR-15b-5p -3.3 0.4 14:41 02:41 0.03
hsa-miR-103a-3p -1.0 0.5 14:44 02:44 0.03
hsa-miR-139-5p -6.4 0.8 15:15 03:15 0.0006
hsa-miR-199a/b-3p 1.3 0.4 16:06 04:06 0.0003
hsa-miR-203-3p -1.9 0.5 17:03 05:03 0.002
hsa-miR-34a-5p 6.4 1.6 17:09 05:09 0.02
hsa-miR-15a-5p -1.4 1.3 17:31 05:31 0.02
hsa-miR-106b-5p -4.3 0.4 17:58 05:58 0.006
hsa-miR-192-5p -5.4 0.9 21:28 09:28 0.0001
doi:10.1371/journal.pone.0160577.t001
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Target analysis of rhythmic plasma miRNAs
The presence of specific, circulating, cell-free miRNAs that display diurnal rhythmicity in
plasma from healthy humans is a novel finding. The mechanisms behind the fluctuations are
unknown. Thus, miRNA-rhythmicity may be due to oscillating transcription, fluctuating
release from cells, fluctuating half-lives, and any combinations of these factors. The putative
functional roles of circulating miRNA are unclear even though a number of studies show that
protein expression may be affected by cell-free miRNA taken up by target cells [39;40]. For that
reason the potential targets of the specific rhythmic miRNAs may be of interest even though
the miRNAs identified here are not envisioned to be functional as translational repressors
while present in the circulation but only after being taken up by target cells or tissues. With the
caveat that this is not experimentally addressed in the present study and that most of the miR-
NAs in the circulation may in fact reflect the end result of cellular disposal we analyzed for tar-
gets in the circadian system and also for common targets using bioinformatics approaches.
In the case of miR-375 –a highly significantly fluctuating miRNA (p< 0.0001) there are a
number of functionally validated targets of possible relevance including transcription factor
SP1 which is among the top 5 transcription factors associated with circadian clocks in mice
[41].MECP2 (methyl CpG binding protein), a circadian-cycle dependent epigenetic regulator
of gene expression in the brain [42] is also a validated target of miR-375. Another interesting
target is RASD1 which regulates responsiveness of the circadian clock and is rhythmically
expressed in the SCN in mouse models [43]. Finally, miR-375 also targetsMYC which com-
petes with the Clock-Bmal1master circadian transcription factor for the same nucleotide
sequence motifs in the genome [44]. The miR-483 (p = 0.0004) is a pineal miRNA and was
shown in rats to target melatonin expression [22].
In mice, miR-155-5p (p< 0.0001) targets the Bmal1mRNA directly and is an important
regulator of the innate immune response that is conditioned across the circadian day in mye-
loid cells [45]. Human miR-155 is homologous to mouse miR-155 (only one nucleotide substi-
tution) and therefore likely to be functionally similar. This proinflammatory miRNA is also
found in lymphocytes and since lymphocyte counts display rhythmicity, i.e. a decline in the
morning and a peak during night [2;46;47], the miR-155 fluctuations observed in plasma may,
at least partly, reflect the physiologically variable lymphocyte counts. Both miR-155-5p and
miR-206 (p = 0.0009) target CCND1, a cell cycle marker that is timed by clock proteins in the
mouse [48]. Also, miR-155-5p targets the CEBPB transcription factor which controls practi-
cally all members of the core circadian clock system [49].
miR-208a-3p (p = 0.003) has Sox-6 as one of its validated targets (as does miR-155-5p) and
Sox-6 expression is negatively correlated with Per1 expression. Per1 is a key circadian gene in
the mouse involved in a negative feed-back loop with the Clock transcription factor [41].
Another miR-208a-3p target, CDKN1A (or p21), is a cyclin-dependent kinase inhibitor con-
trolling G1 cell cycle progression and is circadian in a number of mouse tissues [41]. It is also a
validated target of two other clearly rhythmic miRNAs in the present study, i.e., miR-363-3p
(p = 0.006) and miR-106b-5p (p = 0.006). Finally, the transcription factor est-1, which is yet
another functionally validated miR-208a target, regulates many circadian genes in the SCN
and is down-regulated during the day and upregulated during the night in rats [50].
MiR-139-5p (p = 0.0006) targets IGF1R which together with PDK1 (a kinase downstream of
IGF1R (both IGF1R and PDK1 are targeted by miR-375)) has been shown to be induced by
light in a study of the coupling of cell proliferation with diurnal/circadian cycles in a human
breast cancer model [51]. It also targets ROCK2 that oscillates under the control of the RORα
clock gene, and thus regulates differences in myosin light chain phosphorylation leading to
rhythmicity in the contractility of the vascular system [52].
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miR-106b-5p (p = 0.006) targets CDKN1A (p21) as mentioned above in addition to PTEN
which appears to be involved in the maintenance of circadian rhythm in mouse models [53]. In
addition, p21 is a target of p53 which is targeted by both miR-375 (p = 0.0001) and miR-150-
5p (p = 0.001). In turn, p21 effects the phosphorylation of Rb1, another validated target of
miR-106-5p, and thereby affects cell cycling.
Transcripts of a number of genes involved in epigenetic regulation (acetyltransferases, dea-
cetylases, and DNAmethyltransferases (DNMT1, HDAC4, HDAC7, KAT2B, MECP2)) are
strongly validated targets of the highly significant rhythmic miRNAs found in the present
study. Thus, miR-140-5p (p< 0.0001) targets HDAC4 as well as HDAC7, both histone class II
deacetylases which regulate transcription and are well established circadian regulators [54].
Another epigenetic clock regulator, DNMT1, is also a miR-140-5p target [1]. Finally, a histone
acetyltransferase, KAT2B which is a circadian transcriptional co-activator of activators of clock
genes [55] is targeted by miR-106b-5p.
Systems analysis of rhythmic circulating miRNAs and their targets. Analysis of core
clock gene mRNA sequences reveal that the CRY2mRNA has two weakly interacting miRNAs
among the 26 significantly fluctuating miRNAs found in this study, i.e., miR-106-5p and miR-
24-3p while none targets CRY1. For the Per genes we find that Per1 is a weakly predicted target
for 2 of the fluctuating plasma miRNAs, miR-28-3p and miR-103a-3p, discovered in the pres-
ent study while Per2 is predicted to interact weakly with miR-24-3p and miR-363-3p. None of
the fluctuating miRNAs are predicted to target Per3.
When including the target genes of the 29 miRNAs (for miRNAs 19-3p, 199-3p, and 203-
3p we used a and b as separate miRNAs) in the pathway analyses, no compelling clustering is
visualized except that cell cycling genes and fibroblast and epidermal growth factor receptor-
associated intracellular kinase cascades are shared as targets of a number (> 2) of the cyclic
miRNAs (Fig 3A). Looking at genes of relevance for intracellular signaling we find that a
total of 38 genes (RAPGEF, RAP1B, FGF7, FGF9, EGFR, FGFR3, PDGFRA, PDGFRB, GRB2,
HRAS, KRAS,MAP2K1,MAPK1,MAPK3,MYC, SRF, FOS, STMN1, TNF, TGFB1, TGFBR1,
CASP3, TAB2, PAK2,MAP3K8,MAP2K4, CRKL,MAPK14, JUN, TP53,MEF2C, AKT1,
AKT2, AKT3, HSPA1B,MAP3K14, CHUK, NFKB1) are both among the strong evidence tar-
gets of the cyclic miRNAs as well as situated in the MAPK pathway. These genes are marked
with red in Fig 3B.
Conclusions
The present study identifies circulating miRNAs that undergo clear rhythmic fluctuations in
abundance during a 24-hour period in a group of 24 healthy young male individuals. The find-
ings are specific in the sense that only a third (26/79) of the detected miRNAs display rhyth-
micity and in the sense that two different main phase patterns are observed—one peaking
during night and one pattern peaking during day. Despite the challenge of normalizing data of
circulating miRNA abundance due to the lack of accepted “housekeeping” circulating miRNAs
[34] these observations argue against variations in sampling and RNA purification conditions
leading to the observed differences. Thus, this is, to our knowledge, the first time diurnal varia-
tions in the levels of human circulating, cell-free miRNAs have been reported. The present
study is merely descriptive and does not give a basis for a unifying understanding of the roles
of the individual circadian miRNAs especially because of the general target promiscuity of
miRNAs and because of the uncertainties regarding the regulation of miRNA synthesis, release
to the circulation, and regulation of circulating miRNA removal and degradation. Indeed, a
recent report showed that only 7% (4/57) mature miRNAs originating from oscillating primary
transcripts were rhythmically expressed [21]. Future work involves cellular and animal models
Diurnal Variations of Circulating miRNA
PLOSONE | DOI:10.1371/journal.pone.0160577 August 5, 2016 10 / 15
with targeted miRNA disruption and induction. Also, a confirmative analysis over more than
one diurnal cycle would be valuable.
In any event, the finding that some miRNAs vary according to a diurnal clock is important
information for all studies that include analysis of the levels of circulating miRNAs and the
findings also constitute a starting point for further studies of the importance of miRNA oscilla-
tions in physiology and disease.
Supporting Information
S1 Fig. Graphs of all detected miRNA ΔCq values (V1) as a function of time (hours after
first sample at 09 am). Individual points represent the mean and SEM of the values of the 24
individuals included in the study. In case of significant rhythmicity, the p-values are included
on the graphs.
(PPTX)
S2 Fig. Representations of miR-16 data. Individual data points, mean and SEM are shown for
row mean-normalized, technically normalized, and raw (not normalized) miR-16 data.
(PPTX)
S3 Fig. Graphs of miRNAs detected in the first panel. Comparison side-by-side of row
mean-normalized with row miR-16 normalized data. Data points (mean and SEM) and curve
fitting are shown.
(PPTX)
Fig 3. A, Heatmap showing overrepresented Reactome pathways. For each miRNA all strong targets (defined by miRTarBase) was used for GO
analysis using gProfileR. Only miRNAs where target genes were significantly overrepresented in one or more pathways are shown. Colors indicate p-
value with red colors being associated with lower p-values. Non-significant matches were all assigned the value 0.05. The color bar on top of the plot
indicates groups belonging into 5 time-point specific expression groups (group 1: red, group 2: blue, group 3: green, group 4: black, group 5: pink).B,
MAPK pathway targets. Strongly binding predicted MAPK pathway targets of significant rhythmic miRNAs of the present study are colored red.
doi:10.1371/journal.pone.0160577.g003
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S1 File. Rhytmicity analysis of detected miRNAs by cosinor-rhythmometry using row
mean normalized data. The p-values are indicated in red.
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S2 File. Rhytmicity analysis of detected miRNAs by cosinor-rhythmometry using miR-16
normalized data. The p-values are indicated in red.
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S1 Table. The two miRNA panels employed in this study. Designations (assay name, ID and
miRBase name) and sequences are included. Also indicated are excluded miRNAs based on no
signal (red background) or too few data (light blue background). For the first panel where data
were normalized using both miR-16 and row mean normalization the miRNA in red are those
that were significantly rhythmic using the row mean normalized data only while those that are
written in green are those that were significantly rhythmic using both normalization methods.
(XLSX)
S2 Table. Data file panel 1 and 2. Row mean normalized data for both miRNA panels.
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S3 Table. Data file, panel 1.miR-16 normalized data.
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